Gabapentin Capsule
Product Images NDC 70518-2911

10 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 70518-2911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig-1 (Gabapentin Fig1)

Fig-1 (Gabapentin Fig1)
Illustration of a formula for calculating creatinine clearance (CLCr), including variables for age, weight, serum creatinine levels, and an adjustment factor for female patients. The formula is presented as a mathematical expression.*
FDA Label Image

Chemical Structure (Gabapentin Str)

Chemical Structure (Gabapentin Str)
Chemical structure diagram of the active ingredient Gabapentin, showing the molecular arrangement including a cyclohexane ring with attached amino and carboxyl functional groups.*
FDA Label Image

Figure 1 (Gabapentin Fig2)

Figure 1 (Gabapentin Fig2)
Line graph depicting mean pain score over an 8-week period comparing Placebo and Gabapentin 3600 mg/day. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing more substantially over time for Gabapentin compared to Placebo.*
FDA Label Image

Figure 2 (Gabapentin Fig3)

Figure 2 (Gabapentin Fig3)
A line graph depicting mean pain scores over a 7-week period with three groups: placebo, gabapentin 1800 mg/day, and gabapentin 2400 mg/day. The chart shows a 3-week dose titration period followed by a 4-week fixed dose period, with pain scores decreasing more significantly in the gabapentin groups compared to placebo.*
FDA Label Image

Figure 3 (Gabapentin Fig4)

Figure 3 (Gabapentin Fig4)
Bar graph titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing results from two studies. It compares placebo (PBO) versus gabapentin (GBP) at various dosages (3600 mg in Study 1 and 1800 mg and 2400 mg in Study 2), with GBP groups showing higher responder percentages (29%, 32%, and 34%) than placebo groups (12% and 14%). Statistical significance markers indicate p-values less than 0.01 and 0.001.*
FDA Label Image

Fig-5 (Gabapentin Fig5)

Fig-5 (Gabapentin Fig5)
A scatter plot chart showing percentage difference on the y-axis and daily dose in mg on the x-axis, with data points representing three studies labeled as STUDY a, STUDY b, and STUDY c. Each study is plotted with different markers indicating variation in percentage difference across doses of 600, 900, 1200, and 1800 mg daily.*
FDA Label Image

Mm1 (Gabapentin 300mg 70518 2911 00)

Mm1 (Gabapentin 300mg 70518 2911 00)
Gabapentin Capsule 300 mg oral dosage form packaging label showing quantity of 100 capsules per box. The label includes the NDC number 70518-2911-00, repackager RemedyRepack Inc. based in Indiana, PA, and storage instructions. The capsule is described as yellow. Manufacturer information (Aurobindo Pharma) and additional handling details are also present.*
FDA Label Image

Mm2 (Gabapentin 300mg 70518 2911 01)

Mm2 (Gabapentin 300mg 70518 2911 01)
Gabapentin 300 mg capsule single unit packaging label from RemedyRepack Inc. The label includes NDC 70518-2911-01, manufacturer Aurobindo Pharma, storage instructions, and directions to see the package insert. The package is marked RX only.*
FDA Label Image

Mm3 (Gabapentin 300mg 70518 2911 02)

Mm3 (Gabapentin 300mg 70518 2911 02)
Gabapentin 300 mg capsule label from RemedyRepack Inc. The label shows a quantity of 28 capsules. It includes references to the NDC number 70518-2911-02 and repackaging details by RemedyRepack Inc., Indiana, PA. Manufacturer name Aurobindo Pharma, Dayton, NJ, is also noted. Directions for use refer to the package insert.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Gabapentin 300 mg capsules with a quantity of 100 in the package. The label includes the NDC number 70518-2911-00 and indicates repackaging by RemedyRepack Inc. It instructs to keep the medication out of reach of children and to see the package insert for directions. The original manufacturer is Aurobindo Pharma, Dayton, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.